Search

everythinglearnresearchcommunity

for

Search:↓

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Finasteride reduces prostate size and PSA levels in young patients.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

Dr. Mario Lacouture recommends preventive and specific treatments for skin side effects caused by EGFR inhibitors to improve patients' quality of life.

CT scans can find serious prostate cancer even when PSA levels are low.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Testosterone treatment for older men can have short-term benefits, but long-term risks are unclear, requiring careful evaluation and monitoring.

Men with low testosterone should be carefully evaluated and monitored before and during treatment.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

The true incidence of post-Finasteride syndrome is unclear, and more research is needed.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

Finasteride treats hair loss and reduces prostate cancer risk.

Long-term diabetes is linked to lower prostate cancer risk.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Poor sleep is linked to a higher risk of developing and worsening urinary problems in men.

Finasteride before TURP reduces blood loss and slightly improves early postoperative quality of life.

Good nutrition is crucial for health and preventing disease, and supplements can help prevent nutrient deficiencies.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

Being obese and eating too many calories may increase the risk of kidney cancer, but physical activity doesn't seem to affect this risk.

Higher BMI is linked to a lower risk of non-aggressive prostate cancer and a higher risk of aggressive prostate cancer.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.

Goats with BSE or scrapie show varying symptoms, and using only clinical signs may not detect all scrapie cases.